Results 141 to 150 of about 48,841 (237)

Meta‐Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 10, Page 1348-1361, November 2026.
Placebo arms show substantial improvement in cholestatic pruritus, with up to 30% response rate. Estimates differed across outcome instruments, highlighting the importance of endpoint selection and realistic placebo assumptions in future trial design.
Igor Boechat Silveira   +8 more
wiley   +1 more source

Liver Organoids: From Disease Modelling to Regenerative Medicine

open access: yesCell Proliferation, Volume 59, Issue 11, November 2026.
Liver organoids provide a versatile platform for disease modelling and drug discovery, leveraging stem cells and engineering techniques. They bridge research and clinical applications, offering significant potential for advancing precision medicine and regenerative therapies for liver diseases.
Tiepeng Wang   +5 more
wiley   +1 more source

Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis

open access: yesHepatology Research, Volume 56, Issue 11, Page 1749-1753, November 2026.
ABSTRACT Aim Biallelic pathogenic variants in progressive familial intrahepatic cholestasis (PFIC)‐related genes cause severe pediatric cholestasis. However, the clinical significance of heterozygous variants in adult intrahepatic cholestasis remains unclear.
Shunji Hirose   +9 more
wiley   +1 more source

Pemafibrate Improves Cholestatic Markers Regardless of the Presence of Primary Biliary Cholangitis

open access: yesHepatology Research, Volume 56, Issue 11, Page 1685-1695, November 2026.
Pemafibrate improves liver function markers related to bile flow in primary biliary cholangitis (PBC), but whether this effect is disease‐specific remains unclear. In this study, pemafibrate reduced these markers in patients with and without PBC, suggesting broader effects on bile flow beyond PBC.
Ryohei Tanigawa   +5 more
wiley   +1 more source

Alcohol‐Associated Pancreatitis Confers Higher Risk of Advanced Liver Disease Than Alcohol Withdrawal Syndrome

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 11, Page 3557-3566, November 2026.
ABSTRACT Background and Aim Alcohol‐associated liver disease frequently presents late as decompensated cirrhosis, representing a missed opportunity for intervention. Extrahepatic alcohol‐related presentations requiring acute care, such as alcohol‐associated pancreatitis and alcohol withdrawal syndrome, may identify heavy drinkers at varying risk for ...
Butros Fakhoury   +5 more
wiley   +1 more source

Sclerosing cholangitis from microscopic polyarteritis: an 8-year follow-up case report

open access: yes, 2009
Sclerosing cholangitis from microscopic polyarteritis: an 8-year follow-up case ...
J Co (13409466)   +3 more
core  

Paradoxical hepcidin-iron dysregulation in primary sclerosing cholangitis. [PDF]

open access: yesPLoS One
Kordac P   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy